Economist Conferences – Greece

Speakers
0
sessions
0
attendees
0 +

Greece’s determination to fight cancer

March 12th 2024 | Athenaeum InterContinental Athens Hotel

The achievements-The obstacles-The European reality

Amid the global battle against cancer, Europe stands as a beacon of progress in the field of cancer treatment. Each passing year witnesses significant strides, reflecting a commitment to innovation and collaboration. While challenges persist, the collective efforts of researchers, clinicians, and policymakers have propelled Europe to the forefront of advancements in cancer care.

Greece, nestled within the broader European context, has been forging its path in the realm of cancer treatment with notable dedication and progress. The country’s cancer strategy, intricately woven into the fabric of the European Beating Cancer Plan, reflects a commitment to fostering innovation and accessibility in healthcare.Ā 

Within this context, Economist Impact is organising the Fourth Annual Cancer Summit, entitled ā€œGreece’s determination to fight cancer: The achievements-The obstacles-The European realityā€. This year’s summit, organised under the scientific auspices of the Hellenic Society of Medical Oncology and the auspices of the Hellenic Cancer Federation, provides a unique platform for experts, policymakers and healthcare professionals to collectively assess the nation’s achievements, share insights, and collaboratively shape the trajectory of cancer treatment in Greece.

Ā 

Under the scientific auspices ofĀ  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Under the auspices ofĀ  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Supported byĀ  Ā  Ā  Ā 
Ā Ā Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ā 

Speakers

Eirini Agapidaki

Alternate minister

Sofia Agelaki

Professor of medical oncology

Aris Angelis

Secretary-general for strategic planning

Kostas Athanasakis

Assistant professor in health economics and health technology assessment

Ilias Athanasiadis

Μedical oncologist, director of oncology clinic

Maria Avgoustidou

Medical oncologist

Flora Bacopoulou

Head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics – adolescent medicine

Vassilis Balanis

Chief executive officer

Agenda

8:30 am

Registration and coffee

9:00 am

Welcome and introduction:

Alasdair Ross, countries editor, "The World Ahead 2024", The Economist

Alasdair Ross
Alasdair Ross Countries editor
9:05 am

Official opening session

GREECE’S PROGRESS & FUTURE IN THE FIGHT AGAINST CANCER
ā— Greece’s strategy to fight cancer
ā— HeSMO reflections on cancer priorities
ā— The need for a national cancer plan
ā— Cancer ā€œmovesā€ beyond

Adonis Georgiadis, minister of health, Greece
Zenia Saridaki – Zoras, medical oncologist, president of the BoD, Hellenic Society of Medical Oncology (HeSMO), director, 1st Oncology Dept., Metropolitan Hospital Athens & Asklepios Diagnosis Crete
George Kapetanakis, president, Hellenic Cancer Federation (ELLOK)Ā 
Mike Holmes, vice-president, global medical & scientific affairs oncology therapeutic area, MSD Global

Adonis Georgiadis
Adonis Georgiadis Minister of health
Zenia Saridaki – Zoras
Zenia Saridaki – Zoras Medical oncologist and president of the board
George Kapetanakis
George Kapetanakis President
Mike Holmes
Mike Holmes Vice-president & head, global medical & scientific affairs oncology therapeutic area
9:45 am

Discussion

10:05 am

EU BEATING CANCER PLAN: A LEGACY FOR THE PRESENT AND FUTURE OF CANCER CONTROL IN EUROPE

Andreas Charalambous, past-president, European Cancer Organisation, fmr president, European Oncology Nursing Society, professor oncology and palliative care

Andreas Charalambous
Andreas Charalambous Past-president, European Cancer Organisation, fmr president, European Oncology Nursing Society, professor oncology and palliative care, Cyprus University of Technology
10:10 am

THE LINK BETWEEN PUBLIC HEALTH POLICY, PREVENTION AND CANCER

ā— Public health and cancer prevention policies in Greece
ā— Social inequalities in public policy making
ā— Addressing the issue of inequalities in lung cancer
ā— The establishment of cancer-free cities
ā— The value of investing in patient health literacy

Eirini Agapidaki, alternate minister, Ministry of health, Greece
Yannis Tountas, emeritus professor of social medicine, National and Kapodistrian University of Athens, director, Institute of Social and Preventive Medicine (ISPM)
Andriani Charpidou, pulmonologist, head of clinical trials bureau, 3rd Dept. of Internal Medicine and Laboratory Medical School, National and Kapodistrian University of Athens, "Sotiria" Hospital
Michail Nikolaou, medical oncologist, General Anticancer - Oncology Hospital of Athens ā€œSaint Savvasā€, vice-president of the BoD, HeSMO
Vasiliki-Rafaela Vakouftsi, president, Greek Patients’ Association (recorded message)

Commentators:
Nikolaos Tsoukalas, medical oncologist, director, Oncology Dept., 401 General Military Hospital, General secretary of the BoD, HeSMO
Ioannis Boukovinas
, medical oncologist, head of BIOCLINIC Oncology Unit, Thessaloniki

Moderator:
Mary Bussell, founder, TriMar Strategies

Eirini Agapidaki
Eirini Agapidaki Alternate minister
Yannis Tountas
Yannis Tountas Emeritus professor of social medicine, National and Kapodistrian University of Athens, Director
Andriani Charpidou
Andriani Charpidou Pulmonologist, head of clinical trials bureau, 3rd Dept. of Internal Medicine and Laboratory Medical School
Michail Nikolaou
Michail Nikolaou Medical oncologist, ā€œSaint Savvasā€ General Anticancer Oncology Hospital of Athens, Vice-president of the board
Nikolaos Tsoukalas
Nikolaos Tsoukalas Director, oncology dept., Veterans Hospital 417 NIMTS, General secretary of the board
Ioannis Boukovinas
Ioannis Boukovinas Medical oncologist, Head
Mary Bussell
Mary Bussell Founder
10:45 am

Discussion

11:00 am

A GLOBAL BLUEPRINT FOR CC ELIMINATION - CASE STUDY: SWEDEN

Emily Tiemann, manager, health practice, Economist Impact (recorded message)

Emily Tiemann
Emily Tiemann Manager, health practice
11:10 am

Coffee break

11:40 am

THE VALUE OF EARLY DETECTION OF CANCER

ā— The value of population screening programs
ā— The importance of medical awareness on early identification of cancer care patient in primary care services
ā— The role of referral networks between specialties

Anastasios Boutis, consultant medical oncologist, director, 3rd Med. Oncology Dept., "Theagenio" Anticancer Hospital of Thessaloniki, treasurer of the BoD, HeSMO
Christos Lionis, emeritus professor, general practice and primary health care, School of Medicine, University of Crete (via connection)
Sofia Agelaki, professor of medical oncology University General Hospital of Heraklion, Laboratory of Translational Oncology, Faculty of Medicine, University of Crete

Commentators:
Dimitris Nikas, managing director, Medtronic Hellas
Stylianos Loukides, president, Hellenic Thoracic Society, Professor of Respiratory Medicine, National Kapodistrian University of Athens - Medical School - Attiko University Hospital
Michalis Karamouzis, medical oncologist, professor, medical school, National and Kapodistrian University of Athens

Anastasios Boutis
Anastasios Boutis Consultant medical oncologist, Director, "Theagenio" Anticancer Hospital of Thessaloniki, Treasurer
Christos Lionis
Christos Lionis Emeritus professor, general practice and primary health-care
Sofia Agelaki
Sofia Agelaki Professor of medical oncology
Dimitris Nikas
Dimitris Nikas Managing director
Stylianos Loukides
Stylianos Loukides President, Hellenic Thoracic Society, Professor of Respiratory Medicine
Michalis Karamouzis
Michalis Karamouzis Medical Oncologist, Professor, Medical School
12:10 pm

Discussion

12:25 pm

EU PHARMACEUTICAL LEGISLATION REVISION: THE OPPORTUNITIES ARISING FOR INNOVATIVE THERAPIES

Roberta Savli, executive director of public affairs, European Federation of Pharmaceutical Industries and Associations (via connection)

Roberta Savli
Roberta Savli Executive director of public affairs
12:30 pm

THE VALUE OF EARLY DIAGNOSIS AND MANAGEMENT OF CANCER

ā— The benefits of early management in clinical outcomes
ā— The role of biomarkers & new technologies in personalized cancer careĀ 
ā— The impact of EU HTA regulation in cancer innovation
ā— Ensuring sustainable financing for cancer innovation
ā— The need of investing in early cancer care management

Michalis Liontos, medical oncologist, assistant professor of oncology, department of clinical therapeutics, National and Kapodistrian University of Athens, member of the BoD, HeSMOĀ 
Eleni Kourea, professor of pathology, University of Patras, president, Pathology Society
Flora Bacopoulou, head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics – adolescent medicine, National and Kapodistrian University of Athens
Nandia Gogozotou, non-executive president, EOPYY, president, Drug Price Negotiation Committee
Kostas Athanasakis, assistant professor in health economics and health technology assessment, Department of Public Health Policy, University of West Attica

Commentator:
Ilias Athanasiadis, medical oncologist, director of oncology clinic, Mitera Hospital

Moderator:
Mary Bussell, founder, TriMar Strategies

Michalis Liontos
Michalis Liontos Medical oncologist, Assistant professor of oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Member of the BoD
Eleni Kourea
Eleni Kourea Professor of pathology, University of Patras, President
Flora Bacopoulou
Flora Bacopoulou Head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics – adolescent medicine
Nandia Gogozotou
Nandia Gogozotou Non-executive president, EOPYY, President
Kostas Athanasakis
Kostas Athanasakis Assistant professor in health economics and health technology assessment
Ilias Athanasiadis
Ilias Athanasiadis Μedical oncologist, director of oncology clinic
Mary Bussell
Mary Bussell Founder
1:00 pm

Discussion

1:15 pm

Networking luncheon

2:20 pm

THE PARADIGM SHIFT IN THE CANCER CARE DELIVERY MODEL

ā— The reforms of national health system in Greece
ā— Transforming hospitals into comprehensive cancer care centers
ā— The benefit of holistic care in clinical outcomes
ā— The need for introduction of multi-disciplinary teams in the cancer care delivery model
ā— The benefit of comprehensive cancer centers in cancer patient journey
ā— The value of RWE on the impact of early diagnosis in cancer

Marios Themistocleous, deputy minister of health, Greece (via connection)
Olga Balaoura, president of the board & CEO, General Anticancer - Oncology Hospital of Athens ā€œSaint Savvasā€
Athina Christopoulou, medical oncologist, head, Department of Internal Medicine,Ā 
Division of Clinical Oncology, St. Andrew’s General Hospital of Patra, special secretary of the BoD, HeSMO
Dimitrios Papageorgiou, assistant professor, University of Peloponnese, president, Hellenic Oncology Nursing Society
Paraskevi Michalopoulou, president, Ā Hellenic Association of Women with Breast Cancer ā€œAlma Zoisā€, vice-president, Hellenic Cancer Federation (ELLOK)
Thanassis Lopatatzidis, commercial executive director, AffideaĀ Ā 

Commentator:
Eleni Galani, director, 2nd Oncology Clinic, Metropolitan Hospital
Vassilis Balanis, chief executive officer, National Agency for Quality Assurance in Health (ODIPY)

Marios Themistocleous
Marios Themistocleous Deputy minister of health
Olga Balaoura
Olga Balaoura Chief executive
Athina Christopoulou
Athina Christopoulou Medical oncologist, head, Department of Internal Medicine, Division of Clinical Oncology, St. Andrew’s General Hospital of Patra, Special secretary of the BoD
Dimitrios Papageorgiou
Dimitrios Papageorgiou Assistant professor, University of Peloponnese, President
Paraskevi Michalopoulou
Paraskevi Michalopoulou President, Hellenic Association of Women with Breast Cancer, Vice-president
Thanassis Lopatatzidis
Thanassis Lopatatzidis Commercial executive director
Eleni Galani
Eleni Galani Director, 2nd Oncology Clinic
Vassilis Balanis
Vassilis Balanis Chief executive officer
3:00 pm

Discussion

3:15 pm

THE FUTURE OF INNOVATION IN CANCER

ā— The national strategy for cancer: the way forward
ā— How AI contributes to healthcare
ā— The role of AI in cancer
ā— Digital support of lung cancer patients
ā— The future of clinical trials in cancer

Lilian Venetia Vildiridi, secretary-general for health services, Ministry of Health, Greece
Anastasia Krithara, associate researcher, Institute of Informatics & Telecommunications, NCSR Demokritos, general secretary, Hellenic Artificial Intelligence Society
Nikos Iosif, president, Human Health Intelligence Organization, CEO, Brains I.C.S.
Thanos Kosmidis, co-founder & CEO, Care Across
Christian Hosius, senior clinical director, MSD European Clinical Development

Commentators:
Ioannis Souglakos, medical oncologist, professor of medical oncology, Faculty of Medicine, University of Crete
Emmanouil Saloustros, associate professor of oncology, University of Thessaly,Ā 
member of the BoD, HeSMO (via connection)
Helena Linardou, medical oncologist, director, 4th Oncology, Dept. & Comprehensive
Clinical Trials Center, Metropolitan HospitalĀ 

Lilian Venetia Vildiridi
Lilian Venetia Vildiridi Secretary-general for health services
Anastasia Krithara
Anastasia Krithara Associate researcher, Institute of Informatics & Telecommunications, NCSR Demokritos, General secretary
Nikos Iosif
Nikos Iosif President, Human Health Intelligence Organization, Chief executive
Thanos Kosmidis
Thanos Kosmidis Co-founder & CEO
Christian Hosius
Christian Hosius Senior clinical director
Emmanouil Saloustros
Emmanouil Saloustros Associate professor of oncology, University of Thessaly, Member of the BoD
Helena Linardou
Helena Linardou Medical oncologist, director
3:50 pm

Discussion

4:05 pm

Coffee break

4:25 pm

EU & NATIONAL INVESTMENT OPPORTUNITIES

Sofia Xesfingi, Horizon Europe NCP Health & Cancer Mission, project manager of HNN3.0 & ECHoS in Greece, chair, EEN SG Health

Sofia Xesfingi
Sofia Xesfingi Horizon Europe NCP Health & Cancer Mission, Project manager of HNN3.0 & ECHoS in Greece, Chair
4:30 pm

HOW CAN HEALTHCARE SYSTEMS RESPOND TO PATIENTS’ NEEDS

ā— Ensuring patients’ access to innovative therapies
ā— Beyond cancer: How to improve survivors’ experience
ā— The value of home care and palliative services for cancer patients
ā— The value of digitalization of cancer care
ā— The importance of incorporating patients’ voice in cancer policy planning

Aris Angelis, secretary-general for strategic planning, Ministry of Health, Greece
Amanda Psyrri, professor of medical oncology, National Kapodistrian University of Athens, chairman of internal medicine, Attikon University Hospital
Maria Avgoustidou, medical oncologist, Athens Medical Group
Niki Tsouma, president of the board and CEO, IDIKA, e-Government Center forĀ 
Social Security Services
Dafni Kaitelidou, president, National Agency for Quality Assurance in Health (ODIPY)

Commentator:
Paris Kosmidis, head of the second Medical Oncology Department, Hygeia Hospital,Ā 
former president, ESMO
Athanasios Kotsakis, professor of Medical Oncology, University of Thessaly Medical School, Director, University Oncology Clinic, University Hospital of Larissa (via connection)

Aris Angelis
Aris Angelis Secretary-general for strategic planning
Amanda Psyrri
Amanda Psyrri Professor of medical oncology, National Kapodistrian University of Athens, Chairman of internal medicine
Maria Avgoustidou
Maria Avgoustidou Medical oncologist
Niki Tsouma
Niki Tsouma Chief executive
Dafni Kaitelidou
Dafni Kaitelidou Professor, Department of Nursing, NKUA, Director, Center for Health Services Management and Evaluation, President
Paris Kosmidis
Paris Kosmidis Ī—ead of the second Medical Oncology Department, Hygeia Hospital, Former president
Athanasios Kotsakis
Athanasios Kotsakis Professor of Medical Oncology, University of Thessaly Medical School, Director
5:00 pm

Discussion

5:15 pm

THE ROLE OF CANCER CARE MONITORING IN COVERING PATIENT NEEDS

Thomas Hofmarcher, health economist, Swedish Institute of Health Economics (IHE) (recorded message)

Thomas Hofmarcher
Thomas Hofmarcher Health economist
5:20 pm

Closing remarks:

ā— Cancer priorities in Greece

Zenia Saridaki – Zoras, medical oncologist, president of the BoD, Hellenic Society of Medical Oncology (HeSMO), director, 1st Oncology Dept., Metropolitan Hospital Athens & Ā Asklepios Diagnosis Crete
George Kapetanakis, president, Hellenic Cancer Federation (ELLOK)Ā 

Zenia Saridaki – Zoras
Zenia Saridaki – Zoras Medical oncologist and president of the board
George Kapetanakis
George Kapetanakis President
5:40 pm

End of conference

Sponsors

Delegrate registration

Option A: Conference sessions

€1.800 tax/VAT excl.

  • Full 3-day conference
  • 3 networking luncheons
  • Coffee breaks

Option B: Conference sessions and dinners

€2.200 tax/VAT excl.

  • Full 3-day conference 3
  • networking luncheons coffee breaks and cocktail receptions
  • 2 Gala Dinners

Corporate table

€7.500 tax/VAT excl./ table (8 seats)

  • This option includes participation of 8 persons at: full 3-day conference 3 networking luncheons coffee breaks

Venue

Escape in a haven of relaxation and grandeur by the azure of the sea, delve in the pleasures of luxury and experience the epitome of indulgence in the dreamiest island-like resort of the Athenian Riviera. Nuzzled in a 72-acre private peninsula in the Athenian Riviera with stunning views to the Saronic Gulf, the 5 star Grand Resort Lagonissi exceeds all expectations of a luxury sea front summer resort.

Grand Resort Lagonissi 40th km Athens Sounion, Lagonissi Attica, Athens

Watch live

Contact Us

General information
Phone: (+30) 210 94 08 750
info@hazliseconomist.com

Sponsorships & partnerships
Clarine Kalogeraki
Phone: (+30) 210 94 08 750
clarine@hazliseconomist.com

Commercial department
Konstantinos Sarlas
Phone: (+30) 210 94 08 750 (ext. 210)
ksarlas@hazliseconomist.com


Business development, marketing & sales
Katerina Zacharakopoulou
Phone: (+30) 210 94 08 750
katerina.zach@hazliseconomist.com

Press office
Phone: (+30) 210 94 08 750
press@hazliseconomist.com